The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: A retrospective cohort study and systematic review of the literature

被引:7
|
作者
Karvounis, Evangelos [1 ]
Kappas, Ioannis [1 ]
Angelousi, Anna [2 ]
Makris, George-Marios [3 ]
Siamatras, Thomas D. [1 ]
Kassi, Eva [2 ,4 ]
机构
[1] Euroclin Hosp, Dept Endocrine Surg, Ctr Excellence, 9 Athanasiadou Str, Athens 11521, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Hosp, Dept Internal Med, Athens, Greece
[3] Euroclin Hosp, Dept Gynecol, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Med Sch, Dept Biol Chem, Athens, Greece
关键词
TSH; Tg; thyroglobulin; thyroid cancer; iodine therapy; systematic review; STIMULATING HORMONE RATIO; CANCER; THYROTROPIN; EXPRESSION;
D O I
10.4081/oncol.2020.439
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the present study is to examine the diagnostic and predictive accuracy of the thyroglobulin (Tg) to thyroid stimulating hormone (TSH) and TSH/Tg ratios in normothyroid patients with differentiated thyroid cancer (DTC). We conducted a retrospective cohort study evaluating the diagnostic accuracy of the serum Tg/TSH and TSH/Tg ratios in normothyroid patients with thyroid nodules. We also systematically searched the international literature using the Medline, Cochrane's CENTRAL, Scopus, Clinicaltrials.gov, EMBASE, and Google Scholar databases for evidence concerning the diagnostic and predictive accuracy of these ratios. Overall, 374 patients were identified in our cohort study of whom 240 were treated for benign disease and 134 were treated for DTC. Significant differences were noted in the Tg/TSH and TSH/Tg values among cases with malignant and benign disease (P=0.020). However, the diagnostic ROC curve did not confirm these results (Tg/TSH=0.572 and TSH/Tg=0.428). After searching the international literature, we identified 8 studies. The majority of the included data reported significant differences among patients with benign/malignant disease and those with successful iodine therapy compared to those with disease relapse. However, the clinical relevance was clearer among studies that investigated the usefulness of these ratios in predicting recurrent disease. The findings of our study support that the Tg/TSH ratio increases in patients with DTC and can, thus, become useful in the future as a predictive marker of ablative 131I therapy success. However, given the significant variability of Tg its diagnostic accuracy remains to date minimal; thus, the actual cut-off value that can be used to discriminate cancer cases from benign disease has not been determined yet.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 36 条
  • [1] Thyroglobulin/thyrotropin ratio for predicting long-term response in differentiated thyroid carcinoma: a retrospective study
    Junior, Adriano Francisco De Marchi
    de Macedo, Ana Barbara Trizzotti
    Soares, Carlos Segundo Paiva
    Bolfi, Fernanda
    Iessi, Mariana Riello Gomes
    de Oliveira, Cristiano Claudino
    Koga, Katia Hiromoto
    Moriguchi, Sonia Marta
    Tagliarini, Jose Vicente
    Mazeto, Glaucia Maria Ferreira da Silva
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (04): : 428 - 435
  • [2] Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma
    Hoe, FM
    Charron, M
    Moshang, T
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (01): : 25 - 30
  • [3] The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma
    Castagna, M. G.
    Jury, H. P. Tala
    Cipri, C.
    Belardini, V.
    Fioravanti, C.
    Pasqui, L.
    Sestini, F.
    Theodoropoulou, A.
    Pacini, F.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (08) : E219 - E223
  • [4] The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma
    M. G. Castagna
    H. P. Tala Jury
    C. Cipri
    V. Belardini
    C. Fioravanti
    L. Pasqui
    F. Sestini
    A. Theodoropoulou
    Furio Pacini
    [J]. Journal of Endocrinological Investigation, 2011, 34 : e219 - e223
  • [5] Stimulating thyroglobulin to TSH ratio predict long-term efficacy of 131I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study
    Yin, Xue
    Lu, Chao
    Sun, Danyang
    Ji, Yanhui
    Wang, Yan
    Zheng, Hongyuan
    Ma, Ziyu
    Jia, Qiang
    Tan, Jian
    Zheng, Wei
    [J]. ENDOCRINE, 2024, 84 (03) : 1064 - 1071
  • [6] Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin Diagnostic implication of TSH-stimulated antithyroglobulin antibody
    Nam, H. -Y.
    Paeng, J. C.
    Chung, J. -K.
    Kang, K. W.
    Cheon, G. J.
    Kim, Y.
    Park, D. J.
    Park, Y. J.
    Min, H. S.
    Lee, D. S.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2014, 53 (02): : 32 - 38
  • [7] Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
    Hussain, Syed Zubair
    Zaman, Maseeh Uz
    Malik, Sarwar
    Ram, Nanik
    Asghar, Ali
    Rabbani, Unaib
    Aftab, Nida
    Islam, Najmul
    [J]. JOURNAL OF THYROID RESEARCH, 2014, 2014
  • [8] Preablation Stimulated Thyroglobulin/TSH Ratio As a Predictor of Successful I131remnant Ablation in Patients with Differentiated Thyroid Cancer Following Total Thyroidectomy
    Hussain, Syed Zubair
    Zaman, Maseeh Uz
    Malik, Sarwar
    Ram, Nanik
    Asghar, Ali
    Rabbani, Unaib
    Aftab, Nida
    Islam, Najmul
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [9] A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression
    Zoephel, Klaus
    Wunderlich, Gerd
    Kotzerke, Joerg
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (03): : 552 - 553
  • [10] Diagnostic value of serum preablative TSH-stimulated thyroglobulin (Tg), Tg/24h 131I neck uptake (RAIU) ratio, and Tg/(RAIUxTSH) ratio in patients with differentiated thyroid carcinoma (DTC)
    Salvatori, M.
    Mazza, R.
    Castaldi, P.
    Festa, A.
    Maussier, M. L.
    Perotti, G.
    Giordano, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S223 - S223